| MeSH term | MeSH ID | Detail |
|---|---|---|
| Lung Neoplasms | D008175 | 171 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
Total
2
Tetranor-pgem
Tetranor-pgem is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 73 references associated with Tetranor-pgem in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for Tetranor-pgem
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Tetranor-pgem
NCBI Entrez Crosslinks
All references with Tetranor-pgem
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| pmid:27993290 | ||||
| pmid:27352806 | ||||
| pmid:27906804 | ||||
| pmid: | ||||
| Murphey LJ et al. | Quantification of the major urinary metabolite of PGE2 by a liquid chromatographic/mass spectrometric assay: determination of cyclooxygenase-specific PGE2 synthesis in healthy humans and those with lung cancer. | 2004 | Anal. Biochem. | pmid:15494133 |
| Schweer H et al. | Determination of 11 alpha-hydroxy-9,15-dioxo-2,3,4,5,20-pentanor-19-carboxyprostan oic acid and 9 alpha,11 alpha-dihydroxy-15-oxo-2,3,4,5,20-pentanor-19-carboxyprostanoi c acid by gas chromatography/negative ion chemical ionization triple-stage quadrupole mass spectrometry. | 1990 | Anal. Biochem. | pmid:2278391 |
| Ferretti A et al. | Quantitative analysis of 11 alpha-hydroxy-9,15-dioxo-2,3,4,5,20-pentanor-19-carboxyprostanoic acid, the major urinary metabolite of E prostaglandins in man. | 1983 | Anal. Biochem. | pmid:6846812 |
| Dong LM et al. | Urinary prostaglandin E2 metabolite and gastric cancer risk in the Shanghai women's health study. | 2009 | Cancer Epidemiol. Biomarkers Prev. | pmid:19861525 |
| Nishikawa A et al. | Enhancement of cell proliferation and prostaglandin biosynthesis by 1,8-dihydroxyanthraquinone in the rat large intestine. | 1997 | Carcinogenesis | pmid:9214611 |
| Mutter R et al. | A phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for patients with inoperable stage IIIA/B non-small cell lung cancer. | 2009 | Clin. Cancer Res. | pmid:19276291 |